Global Insulin Delivery Systems Market Growth 2024-2030

Publication ID:

LPI12248809

Publication Date:

December 13, 2024

Pages:

108

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Insulin Delivery Systems market size was valued at US$ 13680 million in 2023. With growing demand in downstream market, the Insulin Delivery Systems is forecast to a readjusted size of US$ 19000 million by 2030 with a CAGR of 4.8% during review period.
The research report highlights the growth potential of the global Insulin Delivery Systems market. Insulin Delivery Systems are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Insulin Delivery Systems. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Insulin Delivery Systems market.
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy. The device configuration may vary depending on design. A traditional pump includes: the pump (including controls, processing module, and batteries), a disposable reservoir for insulin (inside the pump) and a disposable infusion set, including a cannula for subcutaneous insertion (under the skin) and a tubing system to connect the insulin reservoir to the cannula.
An insulin pump is an alternative to multiple daily injections of insulin by insulin syringes or an insulin pen and allows for flexible insulin therapy when used in conjunction with blood glucose monitoring and carbohydrate counting.
Key Features:
The report on Insulin Delivery Systems market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Insulin Delivery Systems market. It may include historical data, market segmentation by Type (e.g., Insulin Pens, Insulin Pumps), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Insulin Delivery Systems market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Insulin Delivery Systems market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Insulin Delivery Systems industry. This include advancements in Insulin Delivery Systems technology, Insulin Delivery Systems new entrants, Insulin Delivery Systems new investment, and other innovations that are shaping the future of Insulin Delivery Systems.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Insulin Delivery Systems market. It includes factors influencing customer ' purchasing decisions, preferences for Insulin Delivery Systems product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Insulin Delivery Systems market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Insulin Delivery Systems market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Insulin Delivery Systems market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Insulin Delivery Systems industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Insulin Delivery Systems market.
Market Segmentation:
Insulin Delivery Systems market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Insulin Pens
Insulin Pumps
Insulin Syringes
Segmentation by application
Homecare
Hospitals & Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Becton, Dickinson and Company
Novo Nordisk
Medtronic
Sanofi
ELI Lilly and Company
Ypsomed Holding
Animas Corporation
Tandem Diabetes Care
Insulet Corporation
Biocon
Key Questions Addressed in this Report
What is the 10-year outlook for the global Insulin Delivery Systems market?
What factors are driving Insulin Delivery Systems market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Insulin Delivery Systems market opportunities vary by end market size?
How does Insulin Delivery Systems break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Insulin Delivery Systems Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Insulin Delivery Systems by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Insulin Delivery Systems by Country/Region, 2019, 2023 & 2030
2.2 Insulin Delivery Systems Segment by Type
2.2.1 Insulin Pens
2.2.2 Insulin Pumps
2.2.3 Insulin Syringes
2.3 Insulin Delivery Systems Sales by Type
2.3.1 Global Insulin Delivery Systems Sales Market Share by Type (2019-2024)
2.3.2 Global Insulin Delivery Systems Revenue and Market Share by Type (2019-2024)
2.3.3 Global Insulin Delivery Systems Sale Price by Type (2019-2024)
2.4 Insulin Delivery Systems Segment by Application
2.4.1 Homecare
2.4.2 Hospitals & Clinics
2.5 Insulin Delivery Systems Sales by Application
2.5.1 Global Insulin Delivery Systems Sale Market Share by Application (2019-2024)
2.5.2 Global Insulin Delivery Systems Revenue and Market Share by Application (2019-2024)
2.5.3 Global Insulin Delivery Systems Sale Price by Application (2019-2024)
3 Global Insulin Delivery Systems by Company
3.1 Global Insulin Delivery Systems Breakdown Data by Company
3.1.1 Global Insulin Delivery Systems Annual Sales by Company (2019-2024)
3.1.2 Global Insulin Delivery Systems Sales Market Share by Company (2019-2024)
3.2 Global Insulin Delivery Systems Annual Revenue by Company (2019-2024)
3.2.1 Global Insulin Delivery Systems Revenue by Company (2019-2024)
3.2.2 Global Insulin Delivery Systems Revenue Market Share by Company (2019-2024)
3.3 Global Insulin Delivery Systems Sale Price by Company
3.4 Key Manufacturers Insulin Delivery Systems Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Insulin Delivery Systems Product Location Distribution
3.4.2 Players Insulin Delivery Systems Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Insulin Delivery Systems by Geographic Region
4.1 World Historic Insulin Delivery Systems Market Size by Geographic Region (2019-2024)
4.1.1 Global Insulin Delivery Systems Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Insulin Delivery Systems Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Insulin Delivery Systems Market Size by Country/Region (2019-2024)
4.2.1 Global Insulin Delivery Systems Annual Sales by Country/Region (2019-2024)
4.2.2 Global Insulin Delivery Systems Annual Revenue by Country/Region (2019-2024)
4.3 Americas Insulin Delivery Systems Sales Growth
4.4 APAC Insulin Delivery Systems Sales Growth
4.5 Europe Insulin Delivery Systems Sales Growth
4.6 Middle East & Africa Insulin Delivery Systems Sales Growth
5 Americas
5.1 Americas Insulin Delivery Systems Sales by Country
5.1.1 Americas Insulin Delivery Systems Sales by Country (2019-2024)
5.1.2 Americas Insulin Delivery Systems Revenue by Country (2019-2024)
5.2 Americas Insulin Delivery Systems Sales by Type
5.3 Americas Insulin Delivery Systems Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Insulin Delivery Systems Sales by Region
6.1.1 APAC Insulin Delivery Systems Sales by Region (2019-2024)
6.1.2 APAC Insulin Delivery Systems Revenue by Region (2019-2024)
6.2 APAC Insulin Delivery Systems Sales by Type
6.3 APAC Insulin Delivery Systems Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Insulin Delivery Systems by Country
7.1.1 Europe Insulin Delivery Systems Sales by Country (2019-2024)
7.1.2 Europe Insulin Delivery Systems Revenue by Country (2019-2024)
7.2 Europe Insulin Delivery Systems Sales by Type
7.3 Europe Insulin Delivery Systems Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Insulin Delivery Systems by Country
8.1.1 Middle East & Africa Insulin Delivery Systems Sales by Country (2019-2024)
8.1.2 Middle East & Africa Insulin Delivery Systems Revenue by Country (2019-2024)
8.2 Middle East & Africa Insulin Delivery Systems Sales by Type
8.3 Middle East & Africa Insulin Delivery Systems Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Insulin Delivery Systems
10.3 Manufacturing Process Analysis of Insulin Delivery Systems
10.4 Industry Chain Structure of Insulin Delivery Systems
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Insulin Delivery Systems Distributors
11.3 Insulin Delivery Systems Customer
12 World Forecast Review for Insulin Delivery Systems by Geographic Region
12.1 Global Insulin Delivery Systems Market Size Forecast by Region
12.1.1 Global Insulin Delivery Systems Forecast by Region (2025-2030)
12.1.2 Global Insulin Delivery Systems Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Insulin Delivery Systems Forecast by Type
12.7 Global Insulin Delivery Systems Forecast by Application
13 Key Players Analysis
13.1 Becton, Dickinson and Company
13.1.1 Becton, Dickinson and Company Company Information
13.1.2 Becton, Dickinson and Company Insulin Delivery Systems Product Portfolios and Specifications
13.1.3 Becton, Dickinson and Company Insulin Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Becton, Dickinson and Company Main Business Overview
13.1.5 Becton, Dickinson and Company Latest Developments
13.2 Novo Nordisk
13.2.1 Novo Nordisk Company Information
13.2.2 Novo Nordisk Insulin Delivery Systems Product Portfolios and Specifications
13.2.3 Novo Nordisk Insulin Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Novo Nordisk Main Business Overview
13.2.5 Novo Nordisk Latest Developments
13.3 Medtronic
13.3.1 Medtronic Company Information
13.3.2 Medtronic Insulin Delivery Systems Product Portfolios and Specifications
13.3.3 Medtronic Insulin Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Medtronic Main Business Overview
13.3.5 Medtronic Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi Insulin Delivery Systems Product Portfolios and Specifications
13.4.3 Sanofi Insulin Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 ELI Lilly and Company
13.5.1 ELI Lilly and Company Company Information
13.5.2 ELI Lilly and Company Insulin Delivery Systems Product Portfolios and Specifications
13.5.3 ELI Lilly and Company Insulin Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 ELI Lilly and Company Main Business Overview
13.5.5 ELI Lilly and Company Latest Developments
13.6 Ypsomed Holding
13.6.1 Ypsomed Holding Company Information
13.6.2 Ypsomed Holding Insulin Delivery Systems Product Portfolios and Specifications
13.6.3 Ypsomed Holding Insulin Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Ypsomed Holding Main Business Overview
13.6.5 Ypsomed Holding Latest Developments
13.7 Animas Corporation
13.7.1 Animas Corporation Company Information
13.7.2 Animas Corporation Insulin Delivery Systems Product Portfolios and Specifications
13.7.3 Animas Corporation Insulin Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Animas Corporation Main Business Overview
13.7.5 Animas Corporation Latest Developments
13.8 Tandem Diabetes Care
13.8.1 Tandem Diabetes Care Company Information
13.8.2 Tandem Diabetes Care Insulin Delivery Systems Product Portfolios and Specifications
13.8.3 Tandem Diabetes Care Insulin Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Tandem Diabetes Care Main Business Overview
13.8.5 Tandem Diabetes Care Latest Developments
13.9 Insulet Corporation
13.9.1 Insulet Corporation Company Information
13.9.2 Insulet Corporation Insulin Delivery Systems Product Portfolios and Specifications
13.9.3 Insulet Corporation Insulin Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Insulet Corporation Main Business Overview
13.9.5 Insulet Corporation Latest Developments
13.10 Biocon
13.10.1 Biocon Company Information
13.10.2 Biocon Insulin Delivery Systems Product Portfolios and Specifications
13.10.3 Biocon Insulin Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Biocon Main Business Overview
13.10.5 Biocon Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂